A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093
Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of BIA 2 093 in the treatment of
epileptic patients with refractory simple or complex partial seizures with or without
secondary generalization.